Elsevier

Progress in Neurobiology

Volume 65, Issue 4, November 2001, Pages 367-390
Progress in Neurobiology

Non-genomic effects of glucocorticoids in the neural system: Evidence, mechanisms and implications

https://doi.org/10.1016/S0301-0082(01)00012-0Get rights and content

Abstract

Complementing the classical concept of genomic steroid actions, here we (i) review evidence showing that important neural effects of glucocorticoids are exerted by non-genomic mechanisms; (ii) describe known mechanisms that may underlie such effects; (iii) summarize the functions and implications of non-genomic mechanisms and (iv) outline future directions of research. The role of non-genomic mechanisms is to shape the response of the organism to challenges that require a substantial reorganization of neural and somatic functions and involve massive behavioral shifts. Non-genomic effects may (i) prepare the cell for subsequent glucocorticoid-induced genomic changes, (ii) bridge the gap between the early need of change and the delay in the expression of genomic effects and (iii) may induce specific changes that in some instances are opposite to those induced by genomic mechanisms. The latter can be explained by the fact that challenging situations require different responses in early (acute) and later (chronic) phases. Data show that non-genomic mechanisms of glucocorticoid action play a role in both pathological phenomena and the expression of ameliorative pharmacological effects. Non-genomic mechanisms that underlie many glucocorticoid-induced neural changes constitute a for long overlooked controlling factor. Despite the multitude and the variety of accumulated data, important questions remain to be answered.

Introduction

There is growing evidence suggesting that neural and hormonal steroids use multiple transduction pathways, either genomic or non-genomic or both. In the case of glucocorticoids, genomic effects are well documented. Gene transcription is affected by these hormones in several steps as follows: (i) glucocorticoids bind to receptor complexes located in the cytoplasm; (ii) the glucocorticoid receptor complexes release associated (mainly heat-shock) proteins upon binding the ligand; (iii) the receptor–ligand complex translocates to the nucleus and binds to specific recognition sites; (iv) gene transcription is enhanced or inhibited depending on the type of the glucocorticoid receptor and the specific genomic site. Because of this mechanism, glucocorticoids induce long term changes in neural function (Joëls and de Kloet, 1994, Webster and Cidlowsky, 1999).

Glucocorticoids affect neural function also via rapidly developing mechanisms that do not involve a genomic component (Duval et al., 1983, Wehling, 1995, Wehling, 1997, Haller et al., 1998b, Borski, 2000, Falkenstein et al., 2000a, Falkenstein et al., 2000b). Non-genomic mechanisms appear to be activated by a series of other steroids as well (progesterone, estrogens, testosterone, aldosterone, vitamin D3, and neurosteroids; McEwen, 1991, Wehling, 1995, Benten et al., 1997, Wehling, 1997, Baulieu, 1998). Evidence accumulated later suggests that non-genomic mechanisms activated by glucocorticoids involve various brain areas, neurotransmitter, and second messenger systems as well as behaviors (Table 1). The overview suggests that non-genomic effects of glucocorticoids are one of the major keys to understand the role of these hormones in controlling brain function. Nevertheless, non-genomic effects of glucocorticoids are still poorly understood. Moreover, discriminating between genomic and non-genomic mechanisms is difficult in some cases.

The aim of this review is to summarize data on the non-genomic effects of glucocorticoids in the neural system. After establishing criteria for differentiating genomic and non-genomic mechanisms, we will (i) summarize experimental evidence for the existence of non-genomic glucocorticoid effects in the neural system; (ii) describe known mechanisms that may underlie such effects; (iii) summarize the functions and implications of non-genomic mechanisms and (iv) outline future directions of research.

Section snippets

Criteria for differentiating genomic and non-genomic effects

The classical genomic mechanism of glucocorticoid action has several particularities that can be used as criteria for differentiating genomic and non-genomic mechanisms. In principle, glucocorticoid effects that are incompatible with the particularities of the genomic mechanism should be considered as being mediated by other (i.e. non-genomic) mechanisms.

Based on the particularities of the genomic mechanism, three criteria have been established for identifying non-genomic mechanisms of

Effects occurring within seconds

Locally applied glucocorticoids (corticosterone, cortisol and/or dexamethasone) rapidly affected spontaneous neuronal firing rate or multiunit activity in various brain regions (Ruf and Steiner, 1967, Michal, 1974, Avanzino et al., 1983, Avanzino et al., 1984, Avanzino et al., 1987a, Saphier and Feldman, 1988, Chen et al., 1991). Dosage is difficult to assess in iontophoretic or microelectrophoretic studies. However, the low currents applied (2–20 nA) suggests that low amounts of

Non-genomic mechanisms of rapid glucocorticoid effects

Neural and behavioral studies clearly show that non-genomic effects of glucocorticoids cannot be explained by one single mechanism. This assumption is supported by the following findings: (i) some rapid, non-genomic effects can be abolished by the blockade of the classical, generically linked GRs (Hua and Chen, 1989, Chen et al., 1991, Liu et al., 1995, Croxtall et al., 2000) while others do not depend on GRs (Venero and Borrell, 1999); (ii) in some instances, the artificial glucocorticoid

The specificity of the effect

Ligand specificity of non-genomic mechanisms activated by glucocorticoids has not always been a concern for those who studied rapid, non-genomic effects of glucocorticoids. When tested, however, glucocorticoid effects were not produced by a number of other steroids (see above). Noteworthy, glucocorticoid effects appear to be different from the effects of neurosteroids as well. As shown above, the effects of glucocorticoids on ligand binding to the GABAA receptor was opposite to the change

Future directions of research

The existence of non-genomic glucocorticoid effects can be considered established, with several possible molecular mechanisms explaining such effects, and various functions controlled by such mechanisms. Thus, theoretical and practical implications of non-genomic glucocorticoid effects are of major importance, and yet, non-genomic effects of glucocorticoids and their implications are poorly understood.

Concluding remarks

The existence of non-genomic mechanisms that mediate part of the effects of glucocorticoids can be considered established. Several molecular mechanisms that can mediate such effects were reviewed in detail. The probable role of these mechanisms is to shape the response of the organism to challenges that require a substantial reorganization of neural and somatic functions and involve massive behavioral shifts. Non-genomic effects may (i) prepare the cell for subsequent glucocorticoid-induced

Acknowledgements

This work was supported by OTKA grant T 025844 and T 025845. We thank to Péter Csermely for his advices.

References (171)

  • S.K Boyd et al.

    Evidence for GABA involvement in stress-induced inhibition of male amphibian sexual behavior

    Horm. Behav.

    (1990)
  • P.F Brain et al.

    Some relationships between adrenal function and isolation-induced intermale aggression in albino mice

    Physiol. Behav.

    (1971)
  • D.W Brann et al.

    Emerging diversities in the mechanism of action of steroid hormones

    J. Steroid. Biochem. Mol. Biol.

    (1995)
  • C.W Breuner et al.

    Noninvasive corticosterone treatment rapidly increases activity in Gambel's white-crowned sparrows (Zonotrichia leucophrys gambelii)

    Gen. Comp. Endocrinol.

    (1998)
  • K.T Britton et al.

    Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress

    Pharmacol. Biochem. Behav.

    (1992)
  • N Calvo et al.

    Methyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress

    Brain Res.

    (1998)
  • S Conte et al.

    Ultradian rhythms in avoidance behavior of DBA mice

    Physiol. Behav.

    (1994)
  • J.D Croxtall et al.

    Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activity

    Biochem. Pharmacol.

    (1995)
  • N.L Da Silva et al.

    Individual housing from rearing modifies the performance of young rats on the elevated plus-maze apparatus

    Physiol. Behav.

    (1996)
  • D Duval et al.

    Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions

    Biochim. Biophys. Acta

    (1983)
  • M.C Foddi et al.

    Effect of psychological stress on [35S]TBPS binding in rat brain

    Pharmacol. Biochem. Behav.

    (1997)
  • C Grau et al.

    Ultradian rhythms in gross motor activity of adult humans

    Physiol. Behav.

    (1995)
  • C Hallahan et al.

    Time course of early events in the action of glucocorticoids on rat thymus cells in vitro. Synthesis and turnover of a hypothetical cortisol-induced protein inhibition of glucose metabolism and of a presumed ribonucleic acid

    J. Biol. Chem.

    (1973)
  • J Haller et al.

    Acute effects of glucocorticoids: behavioral and pharmacological perspectives

    Neurosci. Biobehav. Rev.

    (1998)
  • D.M Hayden-Hixson et al.

    Steroid-specific regulation of agonistic responding in the anterior hypothalamus of male hamsters

    Physiol. Behav.

    (1991)
  • F Homo et al.

    Early effect of steroids on 45calcium uptake by mouse thymocytes

    Biochem. Biophys. Res. Commun.

    (1981)
  • J Ikeda et al.

    Coexpression of c-fos and hsp70 mRNAs in gerbil brain after ischemia: induction threshold, distribution and time course evaluated by in situ hybridization

    Brain Res. Mol. Brain Res.

    (1994)
  • Y Iwasaki et al.

    Non-genomic mechanisms of glucocorticoid inhibition of adrenocorticotropin secretion: possible involvement of GTP-binding protein

    Biochem. Biophys. Res. Commun.

    (1997)
  • M Joëls et al.

    Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems

    Progr. Neurobiol.

    (1994)
  • A.L Johnston et al.

    5-HT and anxiety: promises and pitfalls

    Pharmacol. Biochem. Behav.

    (1986)
  • H Katsuki et al.

    Arachidonic acid as a neurotoxic and neurotrophic substance

    Prog. Neurobiol.

    (1995)
  • G.A Kennett et al.

    Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin

    Brain Res.

    (1986)
  • J.M Koolhaas et al.

    The temporal dynamics of the stress response

    Neurosci. Biobehav. Rev.

    (1997)
  • C Kubli-Garfias

    Chemical structure of corticosteroids and its relationship with their acute induction of lordosis in the female rat

    Horm. Behav.

    (1990)
  • A.M Lefcourt et al.

    Circadian and ultradian rhythms of peripheral cortisol concentrations in lactating dairy cows

    J. Dairy. Sci.

    (1993)
  • S.J Lou et al.

    The rapid inhibitory effect of glucocorticoid on cytosolic free Ca2+ increment induced by high extracellular K+ and its underlying mechanism in PC12 cells

    Biochem. Biophys. Res. Commun.

    (1998)
  • M.D Majewska et al.

    Glucocorticoids are modulators of GABAA receptors in brain

    Brain Res.

    (1985)
  • M.D Majewska

    Antagonist-type interaction of glucocorticoids with the GABA receptor-coupled chloride channel

    Brain Res.

    (1987)
  • I Mandelbrod et al.

    Modification of responses to sensory and hippocampal stimuli in neurons of the rat mediobasal hypothalamus in the presence of iontophoretically applied cortisol

    Brain Res.

    (1981)
  • I Mandelbrod et al.

    The effects of iontophoretic application of putative neurotransmitters on the electrical activity of rat mediobasal hypothalamic neurons in relation to their steroidal sensitivity

    Brain Res.

    (1983)
  • A Marchlewska-Koj et al.

    Acute increase in plasma corticosterone level in female mice evoked by pheromones

    Physiol. Behav.

    (1990)
  • J Marti et al.

    Effects of diazepam and desipramine in the forced swimming test: influence of previous experience with the situation

    Eur. J. Pharmacol.

    (1993)
  • O Marti et al.

    Anterior pituitary response to stress: time-related changes and adaptation

    Int. J. Dev. Neurosci.

    (1998)
  • J.L Abelson et al.

    Hypothalamic–pituitary–adrenal axis activity in panic disorder. 24-Hour secretion of corticotropin and cortisol

    Arch. Gen. Psychiatry

    (1996)
  • G.L Avanzino et al.

    Effects of corticosterone on neurons of reticular formation in rats

    Am. J. Physiol.

    (1987)
  • L.A Benton et al.

    Ultradian adrenocortical and circulatory oscillations in conscious dogs

    Am. J. Physiol.

    (1990)
  • C Bouzat et al.

    Hydrocortisone and 11-desoxycortisone modify acetylcholine receptor channel gating

    Neuroreport

    (1993)
  • I.R Brown et al.

    The cellular stress gene response in brain

    Handbook Exp. Pharmacol.

    (1999)
  • J.C Buckingham

    Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1

    J. Pharmacol.

    (1996)
  • J.C Butte et al.

    Circadian rhythm of corticosterone levels in rat brain

    J. Endocrinol.

    (1976)
  • Cited by (175)

    • Cortisol rapidly increases baroreflex sensitivity of heart rate control, but does not affect cardiac modulation of startle

      2020, Physiology and Behavior
      Citation Excerpt :

      In addition, glucocorticoids can also elicit rapid, non-genomic effects, for instance by binding to the mineralocorticoid membrane receptor [46,47]. The application of glucocorticoids ‘in vitro’ leads to the transcription of mRNA after a latency of 7.5 min [48], which is followed by protein synthesis that occurs within a time period of minutes to hours [49]. While the earliest genomic effects of glucocorticoids on neurons have been observed approx. 30 min after administration [50,51], typically they occur after 60 min.

    • Basal testosterone's relationship with dictator game decision-making depends on cortisol reactivity to acute stress: A dual-hormone perspective on dominant behavior during resource allocation

      2019, Psychoneuroendocrinology
      Citation Excerpt :

      Given the short duration between the last elevated cortisol sample (TSST + 20) and the measurement of behavior (approximately 25 min after the last elevated cortisol sample), it is unlikely that cortisol exerted its effects on behavior via the relatively slow, genomic transcriptional route to suppressing androgenic receptor functioning (Moore and Evans, 1999) seen in studies of chronic cortisol elevation (Tilbrook et al., 2000). Instead, we suspect that elevated levels of cortisol may have altered androgen receptor functioning via rapid, non-genomic pathways (Makara and Haller, 2001; Moore and Evans, 1999) and subsequently altered behavior (Casto and Edwards, 2016). This non-genomic mechanism that explains the moderating effect of an acute cortisol response on the relationship between testosterone and status-relevant behaviors is speculative and in need of further investigation.

    View all citing articles on Scopus
    View full text